From May 5 to 7, 2026, Vitafoods Europe was held at Fira Barcelona Gran Via, Barcelona, Spain. Sichuan Xieli Pharmaceutical Co., Ltd. (hereinafter referred to as "Xieli Pharma") showcased at Booth 3M201, conducting in-depth exchanges with industry peers from multiple countries and regions worldwide.
Exhibition Overview
Founded in 1997, Vitafoods Europe has developed over 29 years into one of the most influential professional exhibitions in the European nutraceutical industry, renowned as a bellwether of industry trends. This edition gathered more than 1,600 exhibitors from over 135 countries and regions, covering raw materials, branded finished products, services and equipment, contract manufacturing and private labeling. The exhibition displayed innovative achievements in nutraceuticals, functional foods and beverages, nutricosmetics and other sectors, serving as an integrated platform for industrial chain exchanges, cooperation and new market opportunity exploration.
Exhibition Performance of Xieli Pharma
Xieli Pharma was at Booth 3M201. The company highlighted its core products in the field of natural plant extraction, including Berberine Hydrochloride, Hesperidin, Rutin, Curcumin, UDCA and TUDCA.
During the exhibition, the team of Xieli Pharma held in-depth talk with customers from Europe, America, Southeast Asia, the Middle East and other regions. The team walked them through the company’s strengths in quality control, production capacity and international certifications, which won extensive attention and recognition. With the growing global demand for natural health raw materials, Xieli Pharma aims to leverage the international platform of Vitafoods to enable more partners to recognize its technical strength and product value.
International Market Insight
Industry trends on display at the exhibition reflect sustained strong growth potential in the dietary supplement market. Key innovation focuses included GLP-1 companion nutrition, longevity and cellular health, clean label and alternative ingredients, as well as the upgrading of pet nutrition segments.
These trends line up well with the product strategy of Xieli Pharma. Guided by the philosophy of "Joint Together to Create a Healthy Career", the company focuses on the R&D, production and sales of characteristic natural-origin APIs. It drives the upgrading and restructuring of the entire industrial chain covering raw material R&D, production management, quality traceability, cross-border trade and end sales through technological innovation. Especially in the plant extraction field, greenness, safety, high efficiency and traceability have become new evaluation criteria in the global market.
Xieli’s products are now available in nearly 50 countries and regions worldwide, and are part of the core supply chains of Fortune Global 500 pharmaceutical giants. The company consistently participates in international exhibitions as a window for technical exchange and a bridge for cooperation docking. In 2025, Xieli Pharma attended major global exhibitions including CPHI Japan in Tokyo, IPhEB Russia, CPHI China in Shanghai and CPHI Southeast Asia in Kuala Lumpur.
The company’s management stated that it will actively seize opportunities amid the restructuring of the global industrial chain, and use professionalism and innovation to boost the value of Chinese natural health API in the global market.
Future Outlook
Xieli Pharma will keep tracking international market dynamics and participate in relevant industry exhibitions in line with business development needs. It will stay up to speed with industry trends, strengthen technological innovation and quality management, maintain communication with global partners, and promote pragmatic cooperation in the field of natural health raw materials.
If you are interested in Xieli Pharma’s products and services, please feel free to contact us through official channels.
